期刊文献+

顺尔宁佐辅舒酮、万托林气雾吸入治疗儿童咳嗽变异性哮喘56例临床体会 被引量:2

下载PDF
导出
摘要 目的观察顺尔宁口服佐辅舒酮和万托林气雾剂吸入治疗儿童咳嗽变异性哮喘的临床疗效。方法56例咳嗽变异性哮喘患儿均给予顺尔宁口服佐辅舒酮和万托林气雾剂吸入治疗。顺尔宁用法:2-5岁4mg;6-14岁5mg均每日一次,睡前服用。辅舒酮(丙酸氟替卡松)气雾剂吸入,每日2次,每次125ug,(3岁以下患儿可用储物罐辅助送气),至咳嗽症状缓解后,停用万托林,但继续用原剂量辅舒酮至症状控制,并维持3个月后,开始减量为125ug,期间根据病情观察、随诊,调整剂量和疗程;万托林气雾吸入每次0.1-0.2mg,发作期每日1-2次。结果根据病情调整剂量和疗程,均控制良好,无一例复发。结论顺尔宁佐辅舒酮、万托林气雾吸入治疗56例咳嗽变异性哮喘患儿,符合GINA治疗原则,值得临床推广应用。
作者 于海玲 杜昊
出处 《当代临床医刊》 2015年第3期1385-1386,共2页 Journal of Contemporary Clinical Medicine
  • 相关文献

参考文献5

二级参考文献31

  • 1顾岑,李跃进.小儿过敏性咳嗽52例临床分析[J].中华儿科杂志,1993,31(2):81-82. 被引量:83
  • 2[1]Gem JE. Viral and bacterial infections in the development and progression of asthma. J Allergy Clin Immumo1,2000,105 (suppl) :497
  • 3[2]Freymuth F, Vabret A, Brouard J, et al. Detection of viral, chlamydia pneumoniae and mycoplasma pneumoniae infections in exacerbations of asthma in children. J Clin Virol,1999,13(3) :131
  • 4[3]Daian CM, Wolff AH, Bielory L, et al. The role of atypical organisms in asthma. Allergy Asthma Proe ,2000 ,21 (2) :107
  • 5[4]Hahn DL, Peeling RW, Dillon E, et al. Serologic markers for chlamydia pneumoniae in asthma. Ann Allergy Asthma Immunol, 2000,84 ( 2 ):227
  • 6[5]Fayon M, Just J, Thien HV, et al. Bacterial flora of the lower respiratory tract in children with bronchial asthma. Acta Pediatr, 1999,88(11) :1216
  • 7Ann Allergy Asthma Immunol[J].2003,90:652.
  • 8中华儿科杂志,2003,41:127-127.
  • 9Dicpinigaitis PV, Dobkin JB, Reichel J. Antitussive effect of the leukotriene receptor antagonist zafirlukast in subjects with cough variant asthma [ J ]. J Asthma, 2002,39 (4) : 291 -- 297.
  • 10Koh YY, Park Y, Jeong JH, et al. Relationship of wheezing to airflow obstruction in asthmatic children and a history of cough variant asthma [ J ]. J Asthma, 2002,39 (4) : 307-- 314.

共引文献215

同被引文献24

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部